Clinical Trial Update: A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults. [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety and immunogenicity of GSK3277511A vaccine in adults; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Disorders

Drugs mentioned

• GSK3277511A

Snippet

Sponsor: GlaxoSmithKline | Conditions: Respiratory Disorders | Phase 1 | Status: COMPLETED | Results posted: 2018-07-23